Bymetric
UK company intelligence
Company Active LTD

Company profile

Nanogenics Limited

UK company 07636591, incorporated on 17 May 2011.

Nanogenics - Delivering Gene Therapy

Nanogenics Limited is a UK company with status Active founded in 2011 based in London.

Company number
07636591
Incorporated
17 May 2011
Companies House status
Active

Company identity

Founded / incorporated
17 May 2011

Company number 07636591

Verify at Companies House
Legal name
NANOGENICS LIMITED
Company type
Private Limited Company
Region
London
Registered address
C/O ARCH LAW LEVEL 2 HUCKLETREE
8 BISHOPSGATE
LONDON
UNITED KINGDOM
EC2N 4BQ
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active LTD
Nanogenics Limited
CRN 07636591
2
Direct and ultimate controller Active PLC
N4 Pharma PLC
CRN 01435584

Company events

Reference milestones and recent Companies House filing stream events.

5 events
22 Jul
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

08 Jul
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

17 May
2011

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2019
Funded years
2019
Age at first award
8 years

Projects

2019 Collaborative R&D Lead participant

Development of a breakthrough anti-fibrotic gene therapy to improve surgical outcomes and reduce re-admission rates for patients with severe glaucoma.

1 Nov 2019 to 31 Jan 2021

Awarded
£346,254
Total cost £494,648

Lifetime risk of permanent sight loss or blindness was estimated to be 1/5 of people globally (DeloitteAccessEconomics-2017). \>2M people(UK) live with sight loss significant enough to have a drastic impact upon their daily lives, with the cost estimated at £28.1Bn (RNIB-2017). Glaucoma is the second leading cause of blindness, with 500,000 UK residents a...

Product types

Collaborative R&D